Document is current
Any future updates will be listed below
-
Authors
Grillot, Nicolas https://orcid.org/0000-0003-2994-1843
Volteau, Christelle
Quillet, Pauline
Ambrosi, Xavier
Caillard, Anaïs
David, Jean-Stéphane
Blet, Alice
Bouzat, Pierre
Blanchet, Laurent
Bruneau, Nathalie
Chebbi, Nidhal
Saint-Genis, Quentin
Figueiredo, Samy
Guinot, Pierre-Grégoire
Joosten, Alexandre
Le Guen, Morgan
Labaste, François
Lasocki, Sigismond
Oudot, Mathieu
Pommier, Maxime
Rousseleau, Damien
Verdonk, Franck
Tching-Sin, Martine
Faurel-Paul, Elodie
Counille, Flavien
Cossé, Charlotte
Flattres Duchaussoy, Delphine
Cinotti, Raphael
Roquilly, Antoine
-
Funding
Funding for this research was provided by:
Ministère de l'Enseignement Supérieur et de la Recherche (French Ministry of Health (PHRC-N-23-0007))
- License Information
-
More Information
Article History
Received: 11 August 2025
Accepted: 11 January 2026
First Online: 16 January 2026
Declarations
:
: The HyPnotiKs trial protocol has been approved by the ethics committee of the Comité de Protection des Personnes Sud Méditerranée V. It will be carried out in accordance with the principles of the Declaration of Helsinki and the Good Clinical Practice guidelines. All participants will be informed about the research before any study procedures and will sign a free and informed consent form. Patients are eligible to be enrolled without the provision of legal surrogate consent if they are unable to express consent due to the emergency and if next of kin cannot be informed within the maximum delay for inclusion. Patients who recover sufficient capacity to provide consent will be asked to consent to continue in the trial. The HyPnotiKs study was registered in December 2024 at http://clinicaltrials.gov with trial registration NCT06733129.
: Not applicable—no details, images, or videos relating to an individual person have been collected as part of this publication.
: The authors declare that they have no competing interests related to this research.
